Danco Laboratories, L.L.C., Petitioner v. Alliance for Hippocratic Medicine, et al.

  1. March 29, 2024

    Hogan Lovells Vet's High Court Debut A Study In Contrasts

    Several weeks ago, when a Hogan Lovells lawyer finally delivered U.S. Supreme Court arguments after 20 years at the firm, she parsed arcane arbitration issues and her words weren't widely heard outside the courtroom. But weeks later and back at the high court podium, her words were heard nationwide when she pointedly spotlighted a judge's use of "anonymous blog posts" in a bombshell abortion ruling.

  2. March 26, 2024

    Jackson Paints Abortion Clash As Microcosm Of Bigger Brawl

    A war of words Tuesday at the U.S. Supreme Court over access to abortion medication marked a climactic moment after a lengthy legal slugfest. But probing questions from Justice Ketanji Brown Jackson illustrated that the main event for reproductive rights was also simply a single round in a much larger fight over the government's regulatory powers.

  3. March 26, 2024

    Breaking Down The Supreme Court's Abortion Pill Arguments

    The same U.S. Supreme Court that undid the federal right to an abortion two years ago seems a lot less keen to limit access to the abortion medication mifepristone.

  4. March 26, 2024

    In Abortion Case, Gorsuch Frets 'Rash' Of National Injunctions

    U.S. Supreme Court Justice Neil Gorsuch renewed his criticisms of nationwide injunctions Tuesday, saying a Texas judge's universal order limiting access to popular abortion medication mifepristone turned a potentially small legal challenge into a national debate.

  5. March 26, 2024

    High Court Wary Of Bid To Limit Abortion Pill Access

    The U.S. Supreme Court seemed skeptical Tuesday of efforts by anti-abortion groups to severely limit access to the abortion medication mifepristone, with several justices appearing unconvinced that the groups had the right to sue over the Food and Drug Administration's regulation of the pill.

  6. March 22, 2024

    Up Next At High Court: Abortion, Jury Trials And Estate Tax

    The U.S. Supreme Court will hear oral arguments this week over the U.S. Food and Drug Administration's decision expanding access to popular abortion pill mifepristone as well as whether juries should determine a defendants' eligibility for repeat offender enhanced sentencing under the Armed Career Criminal Act and how long federal employees have to appeal adverse employment decisions.

  7. February 01, 2024

    Ex-FDA Leaders Urge High Court To Nix Mifepristone Ruling

    Seven former commissioners and acting commissioners of the U.S. Food and Drug Administration told the U.S. Supreme Court on Thursday that a Fifth Circuit decision reinstating some restrictions on mifepristone, a drug used to end early pregnancies and manage miscarriages, threatens the nation's drug approval process.

  8. January 30, 2024

    Scholars, Advocates Tell Justices Mifepristone Limits Must Go

    A mix of scholars, healthcare providers, lawmakers and abortion rights supporters filed three dozen amicus briefs Tuesday, urging the U.S. Supreme Court to reverse a Fifth Circuit decision that reinstated some restrictions on mifepristone, a drug used to end early pregnancies and manage miscarriages.

  9. January 29, 2024

    Justices To Hear Abortion Drug Case Arguments In March

    The U.S. Supreme Court is set to consider live arguments in a case that could determine the future availability of a widely used abortion medication, advancing a matter some regard as the most significant battle over abortion since the justices overruled Roe v. Wade.

  10. January 24, 2024

    Feds Ask Justices To Nix 5th Circ.'s Abortion Pill Limits

    The Biden administration has asked the U.S. Supreme Court to reverse a Fifth Circuit decision upholding a lower court's reinstatement of restrictions on access to the abortion medication mifepristone, saying that the case marks the first time any court has challenged the scientific judgment of U.S. Food and Drug Administration experts by restricting access to an FDA-approved drug.